MCRB
Seres Therapeutics Inc
3.50$
-2.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 58.3% | 48.9% | 48.4% | 46.4% | 40.8% | 27.7% | 40.2% | 33.9% | 35.9% | 35.7% | 27.1% | 41.7% | |
| 46.2% | 35.7% | 32.6% | 22.1% | 37.4% | 22.0% | 35.8% | 31.6% | 33.2% | 33.1% | 25.4% | 15.4% | |
| 46.2% | 35.7% | 32.6% | 22.1% | 37.4% | 22.0% | 35.8% | 31.6% | 33.2% | 33.1% | 25.4% | 15.4% | |
| 4.6% | 2.4% | 2.2% | 5.8% | – | 3.4% | 2.7% | 0.6% | 0.5% | 0.3% | 0.2% | 24.9% | |
| 5.0% | 8.3% | 12.3% | 16.5% | – | – | – | – | – | – | – | – | |
| 104.1% | 112.5% | 117.5% | 127.1% | 86.6% | 90.1% | 69.3% | 77.1% | 69.5% | 68.0% | 77.5% | 66.0% | |
| 21.5% | 27.5% | 28.9% | 33.7% | 36.3% | 29.5% | 19.1% | 21.5% | 15.6% | 14.0% | 16.4% | 19.7% | |
| 1.7% | 1.6% | 2.6% | 2.9% | 4.7% | 6.2% | 5.5% | 6.6% | 6.9% | 7.5% | 9.2% | 11.6% | |
| 2.4% | 1.0% | 1.5% | 1.5% | 4.6% | 2.9% | 1.3% | 1.5% | 1.2% | 1.2% | 2.0% | 1.2% | |
| 27.5% | 28.3% | 29.9% | 31.9% | – | – | – | – | – | – | – | – | |
| -4.1% | -12.5% | -17.5% | -27.1% | 13.4% | 9.9% | 30.7% | 22.9% | 30.5% | 32.0% | 22.5% | 34.0% | |
| -254.8% | -272.8% | -298.4% | -326.7% | -538.5% | -699.6% | -575.8% | -671.3% | -667.1% | -703.7% | -843.7% | -972.3% | |
| 1.7% | 1.8% | 2.1% | 2.4% | 4.3% | 6.2% | 5.3% | 6.1% | 6.1% | 6.4% | 8.1% | 9.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.